Abstract
ObjectiveExamine decision-making regarding when women would prefer to receive reproductive carrier and cancer predisposition screening and from what clinician. Methods20 women completed in-depth interviews via Zoom exploring their views on the provision of reproductive carrier and cancer predisposition screening. Our analysis identified themes related to what informs women’s preferences for when they would like to receive a genetic screening offer and by which clinician. ResultsParticipants’ responses to questions about when they would be interested in receiving genetic screening were best understood through the lens of the Extended Parallel Process Model. Specifically, personal utility of the information, a woman’s family health history and cost were key factors in decision-making. Women considered their clinician’s knowledge and their trust in and relationship with the clinician when deciding from whom they would prefer to receive an offer of genetic screening. ConclusionOB/GYN clinic patients may accept an offer of genetic screening from a knowledgeable and trusted clinician for carrier and cancer predisposition screening preconceptionally or prenatally. Practice implicationsIntegrating genetic reproductive and cancer predisposition screening into the care provided to reproductive age OB/GYN patients may be acceptable to this population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
